Israeli innovations at Charité and BIH
In September 2019, the Israel Innovation Authority (IIA) and Charité-Universitätsmedizin Berlin and the BIH signed a Memorandum of Understanding to cooperate in the field of technological innovation in healthcare and invite interested companies to submit applications to validate and test as well as adapt and/or optimize their healthcare related technology solutions to ultimately advance patient care. We are happy to announce the next steps within this cooperation, a large multinational Call for Proposals.
Charité-Universitätsmedizin Berlin and the Israel Innovation Authority are launching an innovation and validation program in (digital) healthcare solutions. Israeli companies will have the chance to partner with Charité scientists and clinical researchers to validate, test, pilot and/or adapt their impactful innovative healthcare technologies, services and devices. With this call, Charité and Israel Innovation Authority are seeking to establish the cooperation between researchers with excellent clinical and scientific background at Charité and BIH and the huge innovative potential of Israeli companies to successfully advance translational science and ultimately patient care in German healthcare system and beyond.
Project applications may include joint R&D activities as well as clinical trial at every stage, pilot trials and validation activities. In the framework of the International Health-Tech Pilot Program, launched May, 13th by the IIA, interested companies are invited to submit their Expression of Interest to co-develop and/or validate their healthcare related technology and software solutions until July, 2nd 2020. In the second phase of the program (until September 2020), researchers at Charité and BIH will have the opportunity to partner with one of the start-up companies and together apply for project funding at the IIA.
Dr. med. Sein Schmidt
Scientific and Medical Director, Clinical Trial Unit – Clinical Study Center (CSC), BIH, Charité